ARUP Newsroom

Media Resources

Media Contact

Bonnie Stray
media@aruplab.com
801-583-2787 ext 2823

Image of microscopic view of SARS-CoV2 neutralizing antibodies.

ARUP experts evaluated an Emergency Use Authorization assay that detects SARS-CoV-2 neutralizing antibodies such as those pictured.

July 19, 2021

Test That Detects SARS-CoV-2 Neutralizing Antibodies May Hold a Key to Understanding Long-Term Immunity

A new antibody test that has earned EUA from the FDA effectively detects SARS-CoV-2 neutralizing antibodies, according to an analysis recently published by experts at ARUP Laboratories.

Microscopic view of prostate cancer cells.

ARUP is using Deep Bio’s artificial intelligence-based software in research to evaluate how use of the software may aid in detection and classification of prostate cancer cells, such as the cells pictured here.

July 16, 2021

ARUP Collaborates with Deep Bio to Implement Artificial Intelligence in Clinical Research

Deep Bio announced a research collaboration agreement with ARUP Laboratories. Deep Bio’s AI-based prostate cancer diagnosis software will be used for the joint research.

Image of person holding a piece of paper.

July 14, 2021

ARUP Laboratories Reduces Turnaround Time on Panel Analysis by 30% with GenomOncology

GenomOncology announced that ARUP has chosen to extend its use of the GenomOncology (GO) Precision Oncology API Suite by integrating the GO Clinical Trial and Therapy Matching APIs into its workflows.

Illustration of four people on a staircase. Each stands on a different step, holding hands while helping each other up the stairs.

During the pandemic, ARUP hired more people than ever before to fill positions in labs associated with COVID-19 testing. When one of these labs, the Rapid Response Lab, closed, ARUP worked with a hundred employees to help them find other jobs within the company.

July 8, 2021

ARUP Finds New Jobs for Employees Hired During the Pandemic

By the time ARUP’s Molecular Genetics COVID-19 Rapid Response Lab closed due to decreased demand, nearly 100 of the 120 employees hired to work in the lab had been placed in new positions at ARUP.

A woman who donated blood sits while another woman wraps the donor's arm.

A donor collection specialist at the ARUP Blood Services Donor Center in Sandy bandages a donor’s arm after she has finished donating blood. ARUP is seeking donations of O-positive and O-negative blood to help address a critical shortage.

July 6, 2021

ARUP Joins University of Utah Health, Intermountain Healthcare, American Red Cross in Plea for Blood Donations

ARUP Blood Services and University of Utah Health join Intermountain Healthcare and the American Red Cross asking Utahns to donate blood.

Dr. Tracy George stands in a laboratory. She smiles at the camera.

President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration.

July 2, 2021

ARUP’s Clinical Trials Group Lauds FDA Approval of New Precision Therapy to Treat Advanced Systemic Mastocytosis

The FDA recently approved a new precision therapy developed by Blueprint Medicines for adults with advanced systemic mastocytosis, a rare and potentially fatal hematologic malignancy.